NSRX

Quote

Short

News

Articles

Message Board

Nasus Pharma Ltd. (NYSE : NSRX ) News

Nasus Pharma Ltd. (NYSE: NSRX) News Releases

NSRX News Releases

June 01, 2026 08:00:00 am

GlobeNewswire

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

March 25, 2026 09:17:06 am

SeekingAlpha

Nasus Pharma Ltd. reports FY results

March 25, 2026 09:00:00 am

GlobeNewswire

Nasus Pharma Advances NS002 Towards Pivotal Study Following Positive Phase 2; Reports Annual Results and Provides Business Update

March 19, 2026 10:05:58 am

GlobeNewswire

BriefCast Publishes Transcript: Nasus Pharma NS002 Phase 2 Positive Topline Results Webinar Transcript

March 16, 2026 04:30:29 pm

QM US Market Movers News

US Companies Moving the Markets, Evening edition
Mon, Mar 16, 2026 as of 4:00 pm ET

March 16, 2026 10:00:29 am

QM US Market Movers News

US Companies Moving the Markets, Morning edition
Mon, Mar 16, 2026 as of 10.00 am ET

March 16, 2026 07:30:00 am

GlobeNewswire

Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold

March 13, 2026 08:35:00 am

GlobeNewswire

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

March 10, 2026 10:21:44 am

GlobeNewswire

Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th

March 09, 2026 08:30:00 am

GlobeNewswire

Nasus Pharma to Present Topline Analysis from NS002 Intranasal Epinephrine Powder Phase 2 Single and Repeat Dose Clinical Study

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account